General Information of the Compound
| Compound ID |
CP0202067
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(R)-N-(1-oxo-1-((3-(1-phenylcyclopropyl)-3H-imidazo[4,5-b]pyridin-2-yl)methylamino)-3-(2,3,6-trifluorophenyl)propan-2-yl)-1-(trifluoromethyl)cyclopropanecarboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C30H25F6N5O2
|
||||||||||||||||||
| Molecular Weight |
601.551
|
||||||||||||||||||
| Canonical SMILES |
Fc1ccc(F)c(C[C@@H](NC(=O)C2(CC2)C(F)(F)F)C(=O)NCc2nc3cccnc3n2C2(CC2)c2ccccc2)c1F
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C30H25F6N5O2/c31-19-8-9-20(32)24(33)18(19)15-22(40-27(43)28(10-11-28)30(34,35)36)26(42)38-16-23-39-21-7-4-14-37-25(21)41(23)29(12-13-29)17-5-2-1-3-6-17/h1-9,14,22H,10-13,15-16H2,(H,38,42)(H,40,43)/t22-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
AMSKTYLOKZVQRX-JOCHJYFZSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02752, Sodium channel protein type 10 subunit alpha
Protein ID: PT01000, Sodium channel protein type 9 subunit alpha